Solid-phase synthesis of carbocyclic nucleosides

Organic Letters

Volumn 2, Issue 8, 2000, Pages 1065-1067

  Crimmins, Michael T ^a   Zuercher, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE; PALLADIUM;

ARTICLE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOSIDES; PALLADIUM;

EID: 0034689874     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol005614n     Document Type: Article

References (19)

1. (a) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571-623.
2. (b) Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S. R.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50, 10611-10670.
3. (c) Huryn, D.; Okabe, M. Chem. Rev. 1992, 92, 1745-1768.
4. Kavlick, M. F.; Shirasaka, T.; Kojima, E.; Pluda, J. M.; Hiu, F., Jr.; Yarchoan, R.; Mitsuya, H. Antiviral Res. 1995, 28, 133-146.
5. Crimmins, M. T. Tetrahedron 1998, 54, 9229-9272.
6. Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17-21.
7. Abacavir (Ziagen) is the carbocyclic nucleoside formerly known as 1592U89: (a) Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; St. Clair, M. H.; Boone, L. R.; Tisdale, M.; Parry, N.; Reardon, J. E.; Dornsfife, R. E.; Averett, D. R. Krenitsky, T. A. Antimicrob. Agents Chemother. 1997, 41, 1082-1093.
8. (b) Daluge, S. M. U.S. Patent 5,034,-394, 1991.
9. Crimmins, M. T.; King, B. W. J. Org. Chem. 1996, 61, 4192-4193.
10. 13C NMR, IR, and HRMS).
11. MacKeith, R. A.; McCague, R.; Olivo, H. F.; Palmer, C. F.; Roberts, S. M. J. Chem. Soc., Perkin Trans, 1 1993, 313-314.
12. Crimmins, M. T.; King, B. W.; Tabet, E. A. J. Am. Chem. Soc. 1997, 119, 7883-7884.
13. Dixit, D. M.; Leznoff, C. C. J. Chem. Soc., Chem. Commun. 1977, 798-799.
14. Although Pd(0) is commonly employed in the deprotection of resin bound allylic esters (see: Guibe, F. Tetrahedron 1998, 54, 2967-3042 and selected references therein), reactions involving a resin-bound π-allylpalladium intermediate are rare. One example by Trost involves a supported Pd(0) catalyst: Trost, B. M.; Keinan, E. J. Am. Chem. Soc. 1978, 100, 7779-7781.
15. Although Pd(0) is commonly employed in the deprotection of resin bound allylic esters (see: Guibe, F. Tetrahedron 1998, 54, 2967-3042 and selected references therein), reactions involving a resin-bound π-allylpalladium intermediate are rare. One example by Trost involves a supported Pd(0) catalyst: Trost, B. M.; Keinan, E. J. Am. Chem. Soc. 1978, 100, 7779-7781.
16. -1) was used as an internal standard.
17. Trost, B. M.; Madsen, R.; Guile, S. G.; Elia, A. E. H. Angew. Chem., Int. Ed. Engl. 1996, 35, 1569-1572.
18. Nugiel, D. A.; Cornelius, L. A. M.; Corbett, J. W. J. Org. Chem. 1997, 62, 201-203.
19. 3 receptor. Bowler, A. N.; Raven, A.; Olsen, U. B.; Thomsen, C.; Knutsen, L. J. Drug. Dev. Res. 1998, 43, 26.